Mapping and modeling of a strain-specific epitope in the Norwalk virus capsid inner shell

Virology

Volumn 492, Issue , 2016, Pages 232-241

  Parra, Gabriel I ^a   Sosnovtsev, Stanislav V ^a   Abente, Eugenio J ^a   Sandoval Jaime, Carlos ^a   Bok, Karin ^a   Dolan, Michael A ^a   Green, Kim Y ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Caliciviruses; Epitope tagging; Noroviruses

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROTEIN VP1; CAPSID PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTIGENIC VARIATION; ARTICLE; BINDING SITE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; MOUSE; NONHUMAN; NORWALK VIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; VIRUS CAPSID; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; FELINE CALICIVIRUS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CALICIVIRUS, FELINE; CAPSID; CAPSID PROTEINS; EPITOPE MAPPING; EPITOPES; GENE EXPRESSION; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NORWALK VIRUS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES;

EID: 84960413634     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2016.02.019     Document Type: Article

References (52)

1. Atmar R.L., Bernstein D.I., Harro C.D., Al-Ibrahim M.S., Chen W.H., Ferreira J., Estes M.K., Graham D.Y., Opekun A.R., Richardson C., Mendelman P.M. Norovirus vaccine against experimental human Norwalk virus illness. N. Engl. J. Med. 2011, 365:2178-2187.
2. Abente E.J., Sosnovtsev S.V., Sandoval-Jaime C., Parra G.I., Bok K., Green K.Y. The feline calicivirus leader of the capsid protein is associated with cytopathic effect. J. Virol. 2013, 87:3003-3017.
3. Atmar R.L., Opekun A.R., Gilger M.A., Estes M.K., Crawford S.E., Neill F.H., Graham D.Y. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 2008, 14:1553-1557.
4. Bertolotti-Ciarlet A., Crawford S.E., Hutson A.M., Estes M.K. The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J. Virol. 2003, 77:11603-11615.
5. Bok K., Parra G.I., Mitra T., Abente E., Shaver C.K., Boon D., Engle R., Yu C., Kapikian A.Z., Sosnovtsev S.V., Purcell R.H., Green K.Y. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc. Natl. Acad. Sci. USA 2011, 108:325-330.
6. Bogan A.A., Thorn K.S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 1998, 280:1-9.
7. Burgoyne N.J., Jackson R.M. Predicting protein interaction sites: binding hot-spots in protein-protein and protein-ligand interfaces. Bioinformatics 2006, 22:1335-1342.
8. Batten C.A., Clarke I.N., Kempster S.L., Oliver S.L., Bridger J.C., Lambden P.R. Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins. Virology 2006, 356:179-187.
9. Brizzard B. Epitope tagging. Biotechniques 2008, 44:693-695.
10. Czako R., Atmar R.L., Opekun A.R., Gilger M.A., Graham D.Y., Estes M.K. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin. Vaccine Immunol. 2012, 19:284-287.
11. Correia B.E., Bates J.T., Loomis R.J., Baneyx G., Carrico C., Jardine J.G., Rupert P., Correnti C., Kalyuzhniy O., Vittal V., Connell M.J., Stevens E., Schroeter A., Chen M., Macpherson S., Serra A.M., Adachi Y., Holmes M.A., Li Y., Klevit R.E., Graham B.S., Wyatt R.T., Baker D., Strong R.K., Crowe J.E., Johnson P.R., Schief W.R. Proof of principle for epitope-focused vaccine design. Nature 2014, 507:201-206.
12. Chang K.O., Sosnovtsev S.V., Belliot G., King A.D., Green K.Y. Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line. Virology 2006, 353:463-473.
13. Clackson T., Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science 1995, 267:383-386.
14. Cuconati A., Xiang W., Lahser F., Pfister T., Wimmer E. A protein linkage map of the P2 nonstructural proteins of poliovirus. J. Virol. 1998, 72:1297-1307.
15. Debbink K., Donaldson E.F., Lindesmith L.C., Baric R.S. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity. J. Virol. 2012, 86:1214-1226.
16. Estojak J., Brent R., Golemis E.A. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 1995, 15:5820-5829.
17. Green K.Y. Caliciviridae: the Noroviruses. Fields Virology 2007, 949-979. Lippincott, Williams & Wilkins, Philadelphia, PA. H.P. Knipe, P.M. Howley (Eds.).
18. Green K.Y., Lew J.F., Jiang X., Kapikian A.Z., Estes M.K. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 1993, 31:2185-2191.
19. Geginat G., Kaiser D., Schrempf S. Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 31:733-737.
20. Garaicoechea L., Aguilar A., Parra G.I., Bok M., Sosnovtsev S.V., Canziani G., Green K.Y., Bok K., Parreno V. Llama nanoantibodies with therapeutic potential against human norovirus diarrhea. PLoS One 2015, 10:e0133665.
21. Hansman G.S., Natori K., Shirato-Horikoshi H., Ogawa S., Oka T., Katayama K., Tanaka T., Miyoshi T., Sakae K., Kobayashi S., Shinohara M., Uchida K., Sakurai N., Shinozaki K., Okada M., Seto Y., Kamata K., Nagata N., Tanaka K., Miyamura T., Takeda N. Genetic and antigenic diversity among noroviruses. J. Gen. Virol. 2006, 87:909-919.
22. Hutson A.M., Atmar R.L., Marcus D.M., Estes M.K. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J. Virol. 2003, 77:405-415.
23. Hall A.J., Curns A.T., McDonald L.C., Parashar U.D., Lopman B.A. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin. Infect. Dis. 2012, 55:216-223.
24. Hesse S., Neill F.H., Estes M.K., Shanker S., Prasad B.V., Ferreira J., Atmar R.L. Serological responses to a norovirus nonstructural fusion protein after vaccination and infection. Clin. Vaccine Immunol. 2015, 23:181-183.
25. Hutson A.M., Airaud F., LePendu J., Estes M.K., Atmar R.L. Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 2005, 77:116-120.
26. Jiang X., Wang M., Graham D.Y., Estes M.K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 1992, 66:6527-6532.
27. Jung K., Wang Q., Kim Y., Scheuer K., Zhang Z., Shen Q., Chang K.O., Saif L.J. The effects of simvastatin or interferon-alpha on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS One 2012, 7:e41619.
28. Kaiser W.J., Chaudhry Y., Sosnovtsev S.V., Goodfellow I.G. Analysis of protein-protein interactions in the feline calicivirus replication complex. J. Gen. Virol. 2006, 87:363-368.
29. Katayama K., Murakami K., Sharp T.M., Guix S., Oka T., Takai-Todaka R., Nakanishi A., Crawford S.E., Atmar R.L., Estes M.K. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc. Natl. Acad. Sci. USA 2014, 111:E4043-E4052.
30. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
31. Lopman B.A., Hall A.J., Curns A.T., Parashar U.D. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin. Infect. Dis. 2011, 52:466-474.
32. Liao H.X., Bonsignori M., Alam S.M., McLellan J.S., Tomaras G.D., Moody M.A., Kozink D.M., Hwang K.K., Chen X., Tsao C.Y., Liu P., Lu X., Parks R.J., Montefiori D.C., Ferrari G., Pollara J., Rao M., Peachman K.K., Santra S., Letvin N.L., Karasavvas N., Yang Z.Y., Dai K., Pancera M., Gorman J., Wiehe K., Nicely N.I., Rerks-Ngarm S., Nitayaphan S., Kaewkungwal J., Pitisuttithum P., Tartaglia J., Sinangil F., Kim J.H., Michael N.L., Kepler T.B., Kwong P.D., Mascola J.R., Nabel G.J., Pinter A., Zolla-Pazner S., Haynes B.F. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 2013, 38:176-186.
33. Li X., Zhou R., Tian X., Li H., Zhou Z. Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III and V. Virus Res. 2010, 151:142-147.
34. McLellan J.S., Chen M., Joyce M.G., Sastry M., Stewart-Jones G.B., Yang Y., Zhang B., Chen L., Srivatsan S., Zheng A., Zhou T., Graepel K.W., Kumar A., Moin S., Boyington J.C., Chuang G.Y., Soto C., Baxa U., Bakker A.Q., Spits H., Beaumont T., Zheng Z., Xia N., Ko S.Y., Todd J.P., Rao S., Graham B.S., Kwong P.D. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 2013, 342:592-598.
35. Oh M.S., Kim K.S., Jang Y.K., Maeng C.Y., Min S.H., Jang M.H., Yoon S.O., Kim J.H., Hong H.J. A new epitope tag from hepatitis B virus preS1 for immunodetection, localization and affinity purification of recombinant proteins. J. Immunol. Methods 2003, 283:77-89.
36. Parra G.I., Abente E.J., Sandoval-Jaime C., Sosnovtsev S.V., Bok K., Green K.Y. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J. Virol. 2012, 86:7414-7426.
37. Prasad B.V., Hardy M.E., Dokland T., Bella J., Rossmann M.G., Estes M.K. X-ray crystallographic structure of the Norwalk virus capsid. Science 1999, 286:287-290.
38. Parra G.I., Bok K., Taylor R., Haynes J.R., Sosnovtsev S.V., Richardson C., Green K.Y. Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations. Vaccine 2012, 30:3580-3586.
39. Parra G.I., Green K.Y. Sequential gastroenteritis episodes caused by 2 norovirus genotypes. Emerg. Infect. Dis. 2014, 20:1016-1018.
40. Parra G.I., Azure J., Fischer R., Bok K., Sandoval-Jaime C., Sosnovtsev S.V., Sander P., Green K.Y. Identification of a broadly cross-reactive epitope in the inner shell of the norovirus capsid. PLoS One 2013, 8:e67592.
41. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
42. Reeck A., Kavanagh O., Estes M.K., Opekun A.R., Gilger M.A., Graham D.Y., Atmar R.L. Serological correlate of protection against norovirus-induced gastroenteritis. J. Infect. Dis. 2010, 202:1212-1218.
43. Schaffer U., Schlosser A., Muller K.M., Schafer A., Katava N., Baumeister R., Schulze E. SnAvi - a new tandem tag for high-affinity protein-complex purification. Nucleic Acids Res. 2010, 38:e91.
44. Sosnovtsev S.V., Garfield M., Green K.Y. Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome. J. Virol. 2002, 76:7060-7072.
45. Sivasubramanian A., Sircar A., Chaudhury S., Gray J.J. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009, 74:497-514.
46. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol. 2005, 79:14017-14030.
47. Thorn K.S., Bogan A.A. ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions. Bioinformatics 2001, 17:284-285.
48. Takano T., Kusuhara H., Kuroishi A., Takashina M., Doki T., Nishinaka T., Hohdatsu T. Molecular characterization and pathogenicity of a genogroup GVI feline norovirus. Vet. Microbiol. 2015, 178:201-207.
49. Vinje J. Advances in laboratory methods for detection and typing of norovirus. J. Clin. Microbiol. 2015, 53:373-381.
50. Wobus C.E., Thackray L.B., Virgin H.Wt Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 2006, 80:5104-5112.
51. Wobus C.E., Karst S.M., Thackray L.B., Chang K.O., Sosnovtsev S.V., Belliot G., Krug A., Mackenzie J.M., Green K.Y., Virgin H.W. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2004, 2:e432.
52. Yoda T., Suzuki Y., Terano Y., Yamazaki K., Sakon N., Kuzuguchi T., Oda H., Tsukamoto T. Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J. Clin. Microbiol. 2003, 41:2367-2371.